Sir, The Association of Southeast Asian Nations (ASEAN) Economic Community will begin in the end of this year 2015. Ten ASEAN member countries [Indonesia, Thailand, Brunei Darussalam, Philippine, Singapore, Myanmar, Lao People's Democratic Republic (PDR), Vietnam, Malaysia, and Cambodia] will join hands to make nursing better under the ASEAN Mutual Recognition Arrangement (MRA). This MRA is going to provide a platform for nurses to have "free flow of nurses, migration, or nurse mobility" among the ASEAN countries. It is additionally to exchange information and expertise on standards and qualifications, to promote the adoption of best practices on professional nursing services, and to provide opportunities for capacity building and the training of nurses. This arrangement seems to be a good deal for nurses. [1] But, there are some issues that need to think for consideration, especially for nurse migration.
The issue of free flow of nurses does not seem to be free at all because there are some regulations required, consisting of: 1. Bachelor's degree as the minimum level of education, 2. Having at least 3 years of experience in nursing practice, 3. No record of malpractice, and 4. Certification by the country of origin, and compliance with satisfaction with professional development. [1] These requirements, however, become challenges for the countries such as Indonesia, Vietnam, Cambodia, and other countries that still have Diploma nurses as the majority of their nurses' proportion. [2] It points out that free flow of nurses under MRA is not possible to be applied. However, it might not be a challenge for Thailand and the Philippines because they only have bachelor's level for nurses as the basic of their nursing education. But, it still leads to the question whether Thai or Filipino nurses would like to migrate and work in ASEAN countries or not. In addition, Thailand does not have an open policy for foreign nurses nor does it encourage Thai nurses to go abroad. [3] Meanwhile, Filipino nurses like to migrate to Europe and the United States of America, rather Diploma nurse: A player or a spectator in ASEAN mutual recognition arrangement?
than the ASEAN countries. [3] On the other hand, the requirement to pass the national exam in the national language might be another challenge that may burden nurses, for instance, nurses need to pass examinations in the Thai and Indonesian language to work as a nurse in those countries.
Based on those above requirements, the movement of individual nurses to work as a nurse in other countries might not be happening in the end of this year, in 2015 or in the near future. In contrast, nursing education might play a dominant role in ASEAN MRA, [4] because it has been known that MRA expands its scope not just limited to nursing service, but in nursing education and nursing research as well. [1] Therefore, it can be said that diploma nurses can never be players in ASEAN MRA, but would rather be spectators if they do not upgrade their education. So, the author remarks "nurses need to continue their education at least bachelor level as the first degree of professional nurse to take a part in ASEAN MRA."
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Sir, The search of and use of bioactive medicinal agents derived from plants have been accelerated in recent years. Plants are a rich source of a variety of secondary metabolites, such as alkaloids, flavonoids, glycosides, phenols, saponins, tannins, and terpenoids, etc. More than 25% of modern drugs have been derived from plants. Plants are generally studied because of their use in traditional medicinal properties and offer an opportunity to find new compounds and therapeutic uses. It is necessary to explore various plants used in traditional medicine across the globe to fulfill unmet need of human healthcare. [1] Rhamnus nakaharai is a herb that is used as a traditional medicine for gastrointestinal ailments, inflammation, tumors, and asthma in Taiwan. [2] This herb belongs to the family Rhamnaceae and is reported to contain naphthalenic compounds 6-methoxysorigenin, different glycosides, and acylates i.e. 6-methoxysorigenin-8-O-glucoside, alphasorinin, 6-methoxysorigenin-8-rutinoside, peracetate. and perpropionate in the stem bark along with several known compounds. [3] Rhamnus nakaharai is a source of several flavonoids such as quercetin, quercetin 3-O-methyl ether, and kaempferol; it also contains isotorachyrsone and derivatives. [4] A moderate research data for Rhamnus nakaharai is available. 6-methoxysorigenin, glycosides, and acylates derivatives have been studied for antioxidant activity. 6-methoxysorigenin was found to possess strong radical scavenging, metal chelating, and anti-lipid peroxidation activities than other derivatives. [2] Isotorachrysone was also
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reported to inhibit iron-induced lipid peroxidation in rat brain homogenates (IC 50 value of 1.64 ± 0.08 µM).
[5] Results were comparable in potency to butylated hydroxytoluene and more potent than alpha-tocopherol or desferrioxamine. Quercetin glycosides, specifically 3-O-methylquercetin was found to suppress inflammation by managing nitric oxide production induced by lipopolysaccharide through the inhibition of inducible nitric oxide synthase DNA transcription. [2] 3-O-methylquercetin was also reported to inhibit total cAMPand cGMP-phosphodiesterase of guinea pig trachealis. These in vitro and in vivo studies have confirmed anti-inflammatory and bronchodilating effects of 3-O-methylquercetin. [6] Although Rhamnus nakaharai has been used historically in Taiwan in folk medicines, but not enough information is available about the percentage of chemical constituents present in the plant, proper dosages, and safety. A detailed research can propel its use globally.
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